A non-randomized clinical trial to evaluate the effect of fingolimod on expanded disability status scale score and number of relapses in relapsing-remitting multiple sclerosis patients
Abstract Background Multiple sclerosis (MS) is a chronic disease characterized by demyelination, glial activation and axonal degeneration in the central nervous system. At the present, there is no certain remedy for this disease. However, available therapies often attenuate disease progress. Methods...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Wiley
2019-04-01
|
| Serier: | Clinical and Translational Medicine |
| Fag: | |
| Online adgang: | http://link.springer.com/article/10.1186/s40169-019-0228-7 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|